cleistanthin b has been researched along with vincristine in 1 studies
| Studies (cleistanthin b) | Trials (cleistanthin b) | Recent Studies (post-2010) (cleistanthin b) | Studies (vincristine) | Trials (vincristine) | Recent Studies (post-2010) (vincristine) |
|---|---|---|---|---|---|
| 11 | 0 | 5 | 246 | 0 | 117 |
| Protein | Taxonomy | cleistanthin b (IC50) | vincristine (IC50) |
|---|---|---|---|
| Tubulin beta-4A chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta chain | Homo sapiens (human) | 0.5 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 0.5 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 0.5 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 0.5 | |
| Beta-tubulin | Leishmania donovani | 1 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-2B chain | Bos taurus (cattle) | 1.8 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 0.5 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 0.5 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 1.8 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 1.8 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, N; Li, M; Li, YX; Shi, DK; Zhang, W | 1 |
1 other study(ies) available for cleistanthin b and vincristine
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel glycosylated diphyllin derivatives as topoisomerase II inhibitors.
Topics: Apoptosis; Benzodioxoles; Cell Cycle Checkpoints; Cell Line, Tumor; Dioxolanes; DNA Fragmentation; DNA Topoisomerases, Type II; Drug Design; Drug Resistance, Multiple; Glycosylation; Humans; Lignans; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2012 |